BCG immunotherapy - From pathophysiology to clinical practice

Moshe Tishler, Yehuda Shoenfeld*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review


Treatment with Bacillus Calmette-Guérin vaccine is mainly in use for superficial bladder cancer, for which it is given intravesically. Overall, this therapy is safe with only minor side effects. Arthritis secondary to such therapy has been rarely reported and usually responds well to NSAID treatment. The mechanisms leading to such a complication, as well as the clinical data, are discussed.

Original languageEnglish
Pages (from-to)225-229
Number of pages5
JournalExpert Opinion on Drug Safety
Issue number2
StatePublished - Mar 2006


  • Arthritis
  • Autoimmunity
  • BCG vaccination


Dive into the research topics of 'BCG immunotherapy - From pathophysiology to clinical practice'. Together they form a unique fingerprint.

Cite this